DexCom Debt to Equity Ratio 2006-2018 | DXCM
Current and historical debt to equity ratio values for DexCom (DXCM) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. DexCom debt/equity for the three months ending September 30, 2018 was 0.60.
| DexCom Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2018-09-30 | $0.34B | $0.56B | 0.60 |
| 2018-06-30 | $0.34B | $0.48B | 0.70 |
| 2018-03-31 | $0.33B | $0.42B | 0.79 |
| 2017-12-31 | $0.33B | $0.42B | 0.78 |
| 2017-09-30 | $0.32B | $0.38B | 0.84 |
| 2017-06-30 | $0.32B | $0.35B | 0.91 |
| 2017-03-31 | $0.00B | $0.28B | 0.00 |
| 2016-12-31 | $0.00B | $0.28B | 0.00 |
| 2016-09-30 | $0.00B | $0.26B | 0.00 |
| 2016-06-30 | $0.00B | $0.25B | 0.00 |
| 2016-03-31 | $0.00B | $0.23B | 0.00 |
| 2015-12-31 | $0.00B | $0.22B | 0.00 |
| 2015-09-30 | $0.00B | $0.19B | 0.00 |
| 2015-06-30 | $0.00B | $0.17B | 0.01 |
| 2015-03-31 | $0.00B | $0.15B | 0.01 |
| 2014-12-31 | $0.00B | $0.14B | 0.02 |
| 2014-09-30 | $0.00B | $0.12B | 0.03 |
| 2014-06-30 | $0.00B | $0.10B | 0.04 |
| 2014-03-31 | $0.00B | $0.09B | 0.05 |
| 2013-12-31 | $0.01B | $0.08B | 0.06 |
| 2013-09-30 | $0.01B | $0.08B | 0.07 |
| 2013-06-30 | $0.01B | $0.07B | 0.08 |
| 2013-03-31 | $0.01B | $0.07B | 0.09 |
| 2012-12-31 | $0.01B | $0.08B | 0.09 |
| 2012-09-30 | $0.00B | $0.08B | 0.00 |
| 2012-06-30 | $0.00B | $0.09B | 0.00 |
| 2012-03-31 | $0.00B | $0.10B | 0.00 |
| 2011-12-31 | $0.00B | $0.11B | 0.00 |
| 2011-09-30 | $0.00B | $0.11B | 0.00 |
| 2011-06-30 | $0.00B | $0.12B | 0.00 |
| 2011-03-31 | $0.00B | $0.05B | 0.00 |
| 2010-12-31 | $0.00B | $0.06B | 0.00 |
| 2010-09-30 | $0.00B | $0.04B | 0.03 |
| 2010-06-30 | $0.00B | $0.04B | 0.08 |
| 2010-03-31 | $0.01B | $0.05B | 0.11 |
| 2009-12-31 | $0.05B | $-0.02B | -2.48 |
| 2009-09-30 | $0.05B | $-0.01B | -4.91 |
| 2009-06-30 | $0.00B | $0.00B | 0.99 |
| 2009-03-31 | $0.04B | $0.02B | 2.82 |
| 2008-12-31 | $0.04B | $-0.02B | -2.15 |
| 2008-09-30 | $0.06B | $-0.03B | -2.26 |
| 2008-06-30 | $0.00B | $-0.02B | -0.02 |
| 2008-03-31 | $0.06B | $-0.00B | -21.71 |
| 2007-12-31 | $0.06B | $0.01B | 8.58 |
| 2007-09-30 | $0.06B | $0.02B | 3.54 |
| 2007-06-30 | $0.06B | $0.03B | 2.31 |
| 2007-03-31 | $0.06B | $0.04B | 1.71 |
| 2006-12-31 | $0.00B | $0.06B | 0.04 |
| 2006-09-30 | $0.00B | $0.07B | 0.03 |
| 2006-06-30 | $0.00B | $0.08B | 0.02 |
| 2006-03-31 | $0.00B | $0.04B | 0.00 |
| 2005-12-31 | $0.00B | $0.05B | 0.00 |
| 2005-09-30 | $0.00B | $0.06B | 0.00 |
| 2005-06-30 | $0.00B | $0.07B | 0.00 |
| 2005-03-31 | $0.00B | $-0.06B | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $12.681B | $0.719B |
| Dexcom Inc. is developing continuous glucose monitoring systems for people with diabetes. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $94.614B | 22.05 |
| Intuitive Surgical (ISRG) | United States | $57.493B | 56.57 |
| Edwards Lifesciences (EW) | United States | $30.989B | 33.16 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $24.204B | 16.39 |
| IDEXX Laboratories (IDXX) | United States | $17.147B | 48.97 |
| ABIOMED (ABMD) | United States | $14.891B | 107.00 |
| Teleflex (TFX) | United States | $11.882B | 26.97 |
| Hologic (HOLX) | United States | $10.975B | 18.00 |
| Varian Medical Systems (VAR) | United States | $10.750B | 26.63 |
| STERIS (STE) | United Kingdom | $10.017B | 26.58 |
| Masimo (MASI) | United States | $5.861B | 38.00 |
| LivaNova (LIVN) | United Kingdom | $5.634B | 36.17 |
| Globus Medical (GMED) | United States | $5.033B | 31.62 |
| Penumbra (PEN) | United States | $4.629B | 279.52 |
| Integra LifeSciences Holdings (IART) | United States | $4.477B | 21.81 |
| Wright Medical Group (WMGI) | Netherlands | $3.582B | 0.00 |
| Cantel Medical (CMD) | United States | $3.455B | 34.80 |
| Inogen (INGN) | United States | $2.946B | 63.58 |
| Integer Holdings (ITGR) | United States | $2.679B | 22.42 |
| Halyard Health (AVNS) | United States | $2.277B | 20.52 |
| Glaukos (GKOS) | United States | $1.978B | 0.00 |
| OPKO Health (OPK) | United States | $1.954B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.836B | 0.00 |
| Mazor Robotics (MZOR) | Israel | $1.531B | 0.00 |
| AxoGen (AXGN) | United States | $1.275B | 0.00 |
| Nevro (NVRO) | United States | $1.204B | 0.00 |
| Luminex (LMNX) | United States | $1.174B | 42.48 |
| Pacific Biosciences Of California (PACB) | United States | $1.139B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.121B | 178.53 |
| Orthofix (OFIX) | United States | $1.118B | 32.28 |
| CryoLife (CRY) | United States | $1.055B | 92.58 |
| Natus Medical (BABY) | United States | $1.010B | 21.20 |
| Intersect ENT (XENT) | United States | $0.926B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.803B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.765B | 26.77 |
| Mesa Laboratories (MLAB) | United States | $0.763B | 45.10 |
| TransEnterix (TRXC) | United States | $0.622B | 0.00 |
| Veracyte (VCYT) | United States | $0.568B | 0.00 |
| Sientra (SIEN) | United States | $0.515B | 0.00 |
| ViewRay (VRAY) | United States | $0.472B | 0.00 |
| SI-BONE INC (SIBN) | United States | $0.418B | 0.00 |
| Accuray (ARAY) | United States | $0.413B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.402B | 0.00 |
| Neuronetics (STIM) | United States | $0.381B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.340B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.337B | 0.00 |
| Nuvectra (NVTR) | United States | $0.307B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.299B | 0.00 |
| Fluidigm (FLDM) | United States | $0.297B | 0.00 |
| IRadimed (IRMD) | United States | $0.286B | 74.71 |
| RTI Surgical (RTIX) | United States | $0.284B | 44.80 |
| GenMark Diagnostics (GNMK) | United States | $0.249B | 0.00 |
| Corindus Vascular Robotics (CVRS) | United States | $0.232B | 0.00 |
| CRH Medical (CRHM) | Canada | $0.228B | 39.25 |
| Helius Medical Technologies (HSDT) | United States | $0.228B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.224B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.208B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.136B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.124B | 0.00 |
| HTG Molecular Diagnostics (HTGM) | United States | $0.108B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.106B | 0.00 |
| Ra Medical Systems (RMED) | United States | $0.100B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.097B | 0.00 |
| Restoration Robotics (HAIR) | United States | $0.083B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.073B | 0.00 |
| EDAP TMS (EDAP) | France | $0.071B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.070B | 0.00 |
| Viveve Medical (VIVE) | United States | $0.066B | 0.00 |
| Electromed (ELMD) | United States | $0.054B | 25.84 |
| OBALON THERPTCS (OBLN) | United States | $0.048B | 0.00 |
| Xtant Medical Holdings (XTNT) | United States | $0.040B | 0.00 |
| Vermillion (VRML) | United States | $0.038B | 0.00 |
| Navidea Biopharmaceuticals (NAVB) | United States | $0.038B | 0.00 |
| ConforMIS (CFMS) | United States | $0.037B | 0.00 |
| Neovasc (NVCN) | Canada | $0.036B | 0.00 |
| Lianluo Smart (LLIT) | China | $0.029B | 0.00 |
| PAVmed (PAVM) | United States | $0.028B | 0.00 |
| Titan Medical (TMDI) | Canada | $0.027B | 0.00 |
| DarioHealth (DRIO) | Israel | $0.025B | 0.00 |
| Dynatronics (DYNT) | United States | $0.024B | 0.00 |
| ReWalk Robotics (RWLK) | Israel | $0.021B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.021B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.016B | 0.00 |
| American Shared Hospital Services (AMS) | United States | $0.015B | 11.70 |
| Bioanalytical Systems (BASI) | United States | $0.014B | 0.00 |
| Presbia (LENS) | Ireland | $0.013B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.011B | 0.00 |
| Micron Solutions (MICR) | United States | $0.010B | 0.00 |
| Allied Healthcare Products (AHPI) | United States | $0.008B | 0.00 |
| Sunshine Heart Inc (CHFS) | United States | $0.008B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.007B | 0.00 |
| Cesca Therapeutics (KOOL) | United States | $0.006B | 0.00 |
| InspireMD (NSPR) | Israel | $0.005B | 0.00 |
| Avinger (AVGR) | United States | $0.004B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.000B | 0.00 |
| EnteroMedics (RSLS) | United States | $0.000B | 0.00 |
| Amedica (SINT) | United States | $0.000B | 0.00 |
